# Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study

> **NCT02975076** · NA · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 120 (estimated)

## Conditions studied

- Stroke, Acute
- Ischemic Attack, Transient

## Interventions

- **DRUG:** Sanchitongshu
- **DRUG:** placebo of Sanchitongshu
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **DRUG:** placebo of clopidogrel

## Key facts

- **NCT ID:** NCT02975076
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975076, "Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02975076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*